Ascentage Pharma Group International AAPG
NASDAQ AAPG
$15.24 -0.26 (-1.68%)
As of: Nov 11, 2026 · 3:59 PM EST

Ascentage Pharma Group International (AAPG) Debt Ratio (2023)

Updated

Ascentage Pharma Group International's (AAPG) Debt Ratio came in at 0.01 for Q4 2023.

Analysis

Ascentage Pharma Group International (AAPG) Debt Ratio (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 0.33
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 0.23
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 0.55
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 0.41
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -0.06
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 0.56
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 0.51
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 0.31
10 Ascentage Pharma Group International 1.42 Bn 382.83 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 0.01
API Access

Ascentage Pharma Group International Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=AAPG&period=max&api_key=YOUR_API_KEY